This week we look at how artificial intelligence is revolutionizing voice banking for patients with conditions like amyotrophic lateral sclerosis, also known as ALS. In addition, we highlight proposed prescription drug transparency in Medicaid and how the Food and Drug Administration has changed its ... READ MORE >
Life sciences
5 things to know in life sciences: Week of May 15, 2023
This week we look at how changes to accelerated approvals at the U.S. Food and Drug Administration (FDA) are affecting the number of drugs being approved. Also this week, there is news of CVS’s brief foray into clinical trials, the end of the public health emergency for COVID-19, and the costs of the ... READ MORE >
5 things to know in life sciences: Week of May 8, 2023
This week we look at a paper published by the U.S. Food and Drug Administration related to artificial intelligence. We also highlight a statement from the World Health Organization declaring that mpox is no longer a global health emergency, a venture fund focused on blood-related research, and an effort ... READ MORE >
5 things to know in life sciences: Week of May 1, 2023
This week we look at how the world of digital health is facing an uncertain future when it comes to capital investment. We also examine how researchers have developed a "brain decoder" using neural network technology, gene therapy treatments that offer significant benefits but come with a steep cost, and ... READ MORE >
5 things to know in life sciences: Week of April 24, 2023
This week we look at a World Health Organization meeting on mRNA, using artificial intelligence to streamline clinical trials, Food and Drug Administration approval of a new blood cancer treatment and an upcoming Johnson & Johnson spinout. Finally, we highlight the resumption of a phase 2 trial on an ... READ MORE >
5 things to know in life sciences: Week of April 17, 2023
This week we look at a range of topics in the life sciences industry, from drug pricing negotiations and long-COVID-19 treatment to quantum computing in drug development. Each week we highlight five things affecting the life sciences industry. Here's the latest. Drug pricing negotiation policies are ... READ MORE >
5 things to know in life sciences: Week of April 10, 2023
This week we look at a range of topics in the life sciences industry, from the development of pediatric pacemakers to advancements in health care legislation. We also look at the over $1 billion in venture funds launched last week related to life sciences. Each week we highlight five things affecting ... READ MORE >
5 things to know in life sciences: Week of April 3, 2023
This week we highlight the impact of emerging biopharma on the life sciences industry, a new method for delivering gene therapy, an innovative device to improve safety and sleep quality in infants, and a cutting-edge treatment for vision loss caused by age-related macular degeneration. Finally, we look at ... READ MORE >
5 things to know in life sciences: Week of March 27, 2023
This week we look at new cybersecurity standards for medical devices, a newly identified trigger for mood disorders, an implantable insulin delivery system and the exit of a major player in the race for an RSV vaccine. Finally, we continue to watch developments in diversity considerations for clinical ... READ MORE >
5 things to know in life sciences: Week of March 20, 2023
This week we look at a collaboration between two large pharma companies on an Alzheimer's diagnostic, a major change in UK clinical trial regulations and a significant step to approval for an ALS (amyotrophic lateral sclerosis) drug. Finally, we highlight a promising breakthrough in brain implant ... READ MORE >